as 08-04-2025 2:33pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
Founded: | 1985 | Country: | United States |
Employees: | N/A | City: | MARLBOROUGH |
Market Cap: | 14.5B | IPO Year: | 1990 |
Target Price: | $74.73 | AVG Volume (30 days): | 1.8M |
Analyst Decision: | Buy | Number of Analysts: | 13 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 2.41 | EPS Growth: | -17.18 |
52 Week Low/High: | $51.90 - $84.67 | Next Earning Date: | 07-30-2025 |
Revenue: | $4,038,900,000 | Revenue Growth: | 1.29% |
Revenue Growth (this year): | 3.12% | Revenue Growth (next year): | 4.88% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Madaus Martin D | HOLX | Director | May 7 '25 | Buy | $55.24 | 5,445 | $300,760.02 | 5,445 |
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
StockStory
a month ago
Simply Wall St.
a month ago
Zacks
a month ago
Zacks
a month ago
Zacks
a month ago
Barchart
2 months ago
Zacks
2 months ago
Zacks
2 months ago
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.